Newsroom | 10609 results

PRINCETON, N.J.--(BUSINESS WIRE)--BMS Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo and Chemotherapy Followed by Surgery and Adjuvant Opdivo.......

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, announced today that a new human pharmacokinetic (PK) data abstract was presented at the Society of Surgical Oncology (SSO) 2025 Annual Meeting on March 27 – 29, 2025 in Tampa, FL: ePoster P379. The abstract provides new human PK data relevant to R...

DUBLIN--(BUSINESS WIRE)--The "Pediatric Interventional Cardiology Market Report by Device Type, Procedure, End Use, Country and Company Analysis 2025 to 2033" report has been added to ResearchAndMarkets.com's offering. The Pediatric Interventional Cardiology market is poised for substantial growth, with projections estimating an increase from US$ 2.42 billion in 2024 to US$ 4.34 billion by 2033. This remarkable growth, registering a CAGR of 6.68% from 2025 to 2033, is driven by advancements in...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2024. The Company also posted its fourth quarter Letter to Stockholders and corporate presentation to the “Investors” section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and future...

DUBLIN--(BUSINESS WIRE)--The "Spinal Fusion Device Market by Product Type, Surgery Type, End-Users, Region and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. The latest insights in the medical device industry indicate a robust growth trajectory for the spinal fusion device market, which is set to expand from US$ 7.88 billion in 2024 to reach a projected market size of US$ 11.23 billion by the year 2033. The compounded annual growth rate is predicted to b...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Voom Medical Devices, Inc., a leader in minimally invasive orthopedic solutions, is unveiling the new single-use sterile Revcon™ Screw System at the American College of Foot and Ankle Surgeons (ACFAS) annual meeting in Phoenix, AZ from March 26-29, 2025. The commercial launch of the system is slated for May 2025 and will include the highly anticipated debut of the MIBS CoPilot shift + targeting guide. Minimally invasive bunion surgery (MIBS) is rapidly becomin...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Fri...

DUBLIN--(BUSINESS WIRE)--The "Liposuction Surgery Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Liposuction Surgery Devices market is expected to reach US$ 5.24 billion by 2033 from US$ 1.90 billion in 2024, with a CAGR of 11.91% from 2025 to 2033 The growing demand for body shaping, improvements in minimally invasive technologies, and growing awareness of cosmetic procedures are all contribu...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained. “As much as we believe in the enVista platform, patient safety will always be o...

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic implant care, will showcase its latest foot and ankle innovations at the American College of Foot & Ankle Surgery (ACFAS) Annual Meeting in Phoenix, Ariz., from March 27-30, 2025. Among the highlights is the newly FDA 510(k)-cleared Ossera™ AFX Ankle Fusion System, engineered to advance fusion procedures through cutting-edge 3D printing and TIDAL Technology™. "We understand that every surgeon has unique...